157 related articles for article (PubMed ID: 6311062)
1. Human neutrophil elastase does not bind to alpha 1-protease inhibitor that has been exposed to activated human neutrophils.
Zaslow MC; Clark RA; Stone PJ; Calore JD; Snider GL; Franzblau C
Am Rev Respir Dis; 1983 Sep; 128(3):434-9. PubMed ID: 6311062
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils.
Clark RA; Stone PJ; El Hag A; Calore JD; Franzblau C
J Biol Chem; 1981 Apr; 256(7):3348-53. PubMed ID: 6162845
[TBL] [Abstract][Full Text] [Related]
3. Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency.
Dean RT; Nick HP; Schnebli HP
Biochem Biophys Res Commun; 1989 Mar; 159(2):821-7. PubMed ID: 2784675
[TBL] [Abstract][Full Text] [Related]
4. Proteolysis by neutrophils. Relative importance of cell-substrate contact and oxidative inactivation of proteinase inhibitors in vitro.
Campbell EJ; Senior RM; McDonald JA; Cox DL
J Clin Invest; 1982 Oct; 70(4):845-52. PubMed ID: 6181097
[TBL] [Abstract][Full Text] [Related]
5. Enhanced release of elastase and oxidative inactivation of alpha-1-protease inhibitor by stimulated human neutrophils exposed to Pseudomonas aeruginosa pigment 1-hydroxyphenazine.
Ras GJ; Theron AJ; Anderson R; Taylor GW; Wilson R; Cole PJ; van der Merwe CA
J Infect Dis; 1992 Sep; 166(3):568-73. PubMed ID: 1323622
[TBL] [Abstract][Full Text] [Related]
6. Direct effects of neutrophil oxidants on elastase-induced extracellular matrix proteolysis.
McGowan SE; Murray JJ
Am Rev Respir Dis; 1987 Jun; 135(6):1286-93. PubMed ID: 3035975
[TBL] [Abstract][Full Text] [Related]
7. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic inactivation of alpha-1-proteinase inhibitor by a neutrophil metalloproteinase.
Desrochers PE; Weiss SJ
J Clin Invest; 1988 May; 81(5):1646-50. PubMed ID: 3259248
[TBL] [Abstract][Full Text] [Related]
9. Potential mediator of inflammation. Phagocyte-derived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro.
Carp H; Janoff A
J Clin Invest; 1980 Nov; 66(5):987-95. PubMed ID: 6253528
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase-induced inactivation of alpha 1-antiprotease in hamsters.
Zaslow MC; Clark RA; Stone PJ; Calore J; Snider GL; Franzblau C
J Lab Clin Med; 1985 Feb; 105(2):178-84. PubMed ID: 2982979
[TBL] [Abstract][Full Text] [Related]
11. Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar macrophages from healthy smokers requires the presence of myeloperoxidase.
Wallaert B; Gressier B; Aerts C; Mizon C; Voisin C; Mizon J
Am J Respir Cell Mol Biol; 1991 Nov; 5(5):437-44. PubMed ID: 1657063
[TBL] [Abstract][Full Text] [Related]
12. Erythrocytes protect alpha-1-proteinase inhibitor from oxidative inactivation induced by chemicals, the myeloperoxidase-H2O2-halide system and stimulated polymorphonuclear leukocytes.
Nowak D; Piasecka G
Exp Pathol; 1991; 42(1):47-58. PubMed ID: 1652455
[TBL] [Abstract][Full Text] [Related]
13. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
Hubbard RC; Ogushi F; Fells GA; Cantin AM; Jallat S; Courtney M; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1289-95. PubMed ID: 2824559
[TBL] [Abstract][Full Text] [Related]
14. Ceruloplasmin: plasma inhibitor of the oxidative inactivation of alpha 1-protease inhibitor.
Taylor JC; Oey L
Am Rev Respir Dis; 1982 Sep; 126(3):476-82. PubMed ID: 6289706
[TBL] [Abstract][Full Text] [Related]
15. [Neutrophil elastase and alpha 1-proteinase inhibitor in the gingival fluid of patients with inflammatory diseases of the periodontium].
Borovskiĭ EV; Paskhina TS; Pustovoĭt EV; Platonova LV; Kocherzhinskiĭ VV
Stomatologiia (Mosk); 1988; 67(3):25-7. PubMed ID: 3046061
[No Abstract] [Full Text] [Related]
16. Different selectivities of oxidants during oxidation of methionine residues in the alpha-1-proteinase inhibitor.
Maier KL; Matejkova E; Hinze H; Leuschel L; Weber H; Beck-Speier I
FEBS Lett; 1989 Jul; 250(2):221-6. PubMed ID: 2546797
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of alpha-1-proteinase inhibitor in serum by stimulated human polymorphonuclear leucocytes. Evidence for a myeloperoxidase-dependent mechanism.
Shock A; Baum H
Cell Biochem Funct; 1988 Jan; 6(1):13-23. PubMed ID: 2832092
[TBL] [Abstract][Full Text] [Related]
18. Oxidants from neutrophil myeloperoxidase do not enhance elastase-induced emphysema in the hamster.
Stone PJ; Lucey EC; Breuer R; Christensen TG; Zaslow MC; Clark RA; Franzblau C; Snider GL
Respiration; 1993; 60(3):137-43. PubMed ID: 8210717
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils.
Padrines M; Schneider-Pozzer M; Bieth JG
Am Rev Respir Dis; 1989 Mar; 139(3):783-90. PubMed ID: 2784294
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.
Goldstein W; Döring G
Am Rev Respir Dis; 1986 Jul; 134(1):49-56. PubMed ID: 2425673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
